Car-T patient story

Patient experience of CAR T-cell therapy

February 14, 2020

“I’m afraid around 50% of your bone marrow is made up of blast cells”. That’s not exactly the news you want after already enduring UKALL14 induction, two rounds of FLAG-Ida and a non-related donor bone marrow transplant to treat your acute lymphoblastic leukaemia.

Know More

There is a strong woman, her name is Zainab. She’s 26 years old, and she comes from Pakistan. Why I say she’s strong? Here is her story.

Aug 02, 2019

A wonderful wedding is every woman’s dream, and she was going to marry the man she loves. Everything was perfect, and everyone was busy to prepare the wedding. And suddenly things changed

Know More

Emily has been living a healthy life for more than 7 years after received CAR-T Treatment

February 02, 2019

Emily was the first child to receive CAR-T therapy. She has been living a healthy life for more than 7 years since she got the CAR-T treatment. She is also considered as one of the representatives of such an unprecedented therapy.

Know More

Junaid, 19, was diagnosed with "acute B lymphocytic leukemia

Aug 02, 2019

Junaid, 19, was diagnosed with "acute B lymphocytic leukemia" after multiple tests at a Pakistani hospital for recurrent fever

Know More

Maisha, a 4.5 years old girl comes from Pakistan.

Aug 02, 2019

Maisha, a 4.5 years old girl comes from Pakistan. In September 2014, has the first symptoms "fever and cough"

Know More

29-years-old man comes from Hong Kong

Aug 02, 2019

The Excellent CAR-T Clinical Trial Saves Hong Kong ALL Patient Shawn, 29-years-old man comes from Hong Kong

Know More

Bone Marrow Transplantation Make Acute Myeloid Leukemia Kid Got into Complete Remission

Aug 02, 2019

>Bone Marrow Transplantation Make Acute Myeloid Leukemia Kid Got into

Know More

Cart Cell Therapy Saves Children with Leukemia in China

Aug 02, 2019

>China Car-t Save Leukemia Children,Cart Cell Therapy Saves Children with Leukemia in China

Know More

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

Aug 02, 2019

>Chimeric antigen receptor (CAR) gene therapy is a breakthrough technology in treating refractory hematologic malignancies

Know More

CD19-CAR-T cell immunotherapy for refractory/relapse B-ALL patients

Aug 02, 2019

>CD19-CAR-T cell immunotherapy for refractory/relapse B-ALL patients could result in high CR /incomplete count recovery (CRi) rate including extramedullary leukemia.

Know More

the earlier you start your treatment, the higher your chances to achieve Complete Remission (CR)

apply